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Abstract
Patients who undergo partial nephrectomy (PN) may exhibit renal function insufﬁciency, and a subset of these patients achieves renal
function recovery. We evaluated the predictors of renal insufﬁciency and subsequent renal function recovery following PN. Data on
393 patients who underwent PN for solid renal tumors between March 2001 and November 2013, obtained from 6 institutions, were
retrospectively reviewed. Renal insufﬁciency was deﬁned as new onset of chronic kidney disease stage ≥3 postoperatively on the
second of 2 consecutive tests. Renal function recovery was deﬁned as an estimated glomerular ﬁltration rate ≥60ml/minute/1.73m2
following renal insufﬁciency. Tumor complexity was stratiﬁed according to the RENAL classiﬁcation system. The median (interquartile
range) age, tumor size, and follow-up period were 53 (45–63) years, 2.6 (1.9–3.8) cm, and 36 (12–48) months, respectively. Tumors
were of low complexity in 258/393 (65.6%) of cases. Renal insufﬁciency developed in 54/393 (13.5%) patients, in which age ≥60
years and preoperative creatinine ≥1.1mg/ml were independent predictors. Tumor complexity, clamp type, and operative method
were not signiﬁcant prognostic factors. Among patients with newly developed renal insufﬁciency, 18/54 (33.3%) patients exhibited
renal function recovery within a median period of 18 months, of which preoperative creatinine <1.1mg/ml was an independent
predictor. Age ≥60 years and preoperative creatinine ≥1.1mg/ml were risk factors for renal insufﬁciency following PN. Patients with
renal insufﬁciency whose preoperative creatinine was <1.1mg/ml were likely to have renal function recovery.
Abbreviations: CT = computed tomography, EBL = estimated blood loss, eGFR = estimated glomerular ﬁltration rate, HR =
hazard ratio, MRI = magnetic resonance imaging, PN = partial nephrectomy, PSM = positive surgical margin, RCC = renal cell
carcinoma, WIT = warm ischemia time.
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11. Introduction
The National Comprehensive Cancer Network guidelines
recommend partial nephrectomy (PN) as the treatment of choice
for cT1 tumors.[1] PN was originally indicated if radical
nephrectomy would render the patient functionally anephric,
necessitating dialysis, such as for renal cell carcinoma (RCC) in a
solitary kidney, RCC in 1 kidney with inadequate contralateral
renal function, or bilateral synchronous RCC. There is
accumulating evidence that the oncologic outcomes of PN are
comparable to those of radical nephrectomy.[2,3] Moreover, PN
allows preservation of renal function, decrease in overall
mortality, and reduced risk of cardiovascular events.[4,5] Hence,
over the past decade, PN has become the standard of care for
most technically resectable renal tumors.[6] In Korea, the
proportion of PN performed has rapidly increased from 2008
to 2014.[7]
As a surrogate for the success of the PN, the trifecta outcome
was investigated, which represents no complications, negative
surgical margins, and warm ischemia time (WIT) <25
minutes.[8] In addition to the trifecta outcome, long-term renal
function was another parameter used to prove the success of PN
as one of the pentafecta outcomes.[9] Several factors, including
WIT, loss of parenchymal volume, and ischemic damage in
preserved tissue during the operation, are known renal function
risk factors after PN. These factors are closely related to various
Lee et al. Medicine (2019) 98:18 Medicinesurgical factors such as clamping methods, surgical methods,
and renorrhaphy. However, published data from a multicenter
database of patients with an initial diagnosis of RCC after PN is
scarce. Moreover, to the best of our knowledge, no study has
reported predictors of renal function recovery following renal
insufﬁciency in patients who underwent PN. The aims of this
multicenter analysis were to predict renal insufﬁciency and to
identify the prognostic factors of subsequent renal function
recovery following PN.
2. Materials and methods
2.1. Study population and data collection
A total of 393 consecutive Korean patients with RCC treated
with PN were selected from the multi-center, Severance
Urological Oncology Group PN registry. Data on patients
who underwent PN for RCC between March 2001 and
November 2013, obtained from 6 institutions, were retrospec-
tively reviewed. The present study’s retrospective protocol was
reviewed and approved by the Yonsei University Health System
Ethics Committee, which waived the requirement for informed
consent (2019-005-001). The patient records were anonymized
and de-identiﬁed prior to analysis. Patient demographics,
including age, sex, body mass index, and a history of
hypertension or diabetes mellitus, were collected. Perioperative
and postoperative outcomes were assessed, including American
Society of Anesthesiologists score, tumor size, RENAL nephr-
ometry score, intraoperative surgical complications, operative
time, clamp type, ischemic time, estimated blood loss (EBL), and
serum chemistry.
Preoperative radiological examination data (computed
tomography [CT] or magnetic resonance imaging [MRI]) of
the enrolled patients were interpreted by radiologists in the
urology department at each participating hospital. The ﬁnal
pathology was determined using surgical specimens and
reported by the uropathologists at each institution. Pathologi-
cal data included pathological tumor size, TNM stage,
Fuhrman grade, positive surgical margin (PSM), and histologi-
cal subtype.
Tumor complexity was stratiﬁed according to the RENAL
classiﬁcation system[10]: low (RENAL nephrometry score 7)
or high (RENAL nephrometry score ≥8). Postoperative
complications (30 days after surgery) were graded according
to the modiﬁed Clavien-Dindo classiﬁcation.[11] Trifecta
achievement was deﬁned as a WIT of <25minutes, negative
surgical margins, and no complications intraoperatively or
postoperatively (Clavien-Dindo complication grade ≥3) as a
surrogate of surgical quality. The estimated glomerular
ﬁltration rate (eGFR) was determined using the Modiﬁcation
of Diet in Renal Disease formula.[12] Renal insufﬁciency was
deﬁned as a new onset eGFR <60ml/minute/1.73m2 (chronic
kidney disease stage ≥3) postoperatively on the second of 2
consecutive tests at least 3 months apart. Renal function
recovery was deﬁned as eGFR ≥60ml/minute/1.73m2 follow-
ing renal insufﬁciency.
Patients without notable complications were followed up
with serum chemistries every 3 months for 2 years. Thereafter,
the decision of follow up protocols after surgical treatment was
based on the surgeons’ discretion. All patients received standard
care according to contemporary guidelines for the duration of
follow-up.22.2. Study endpoints
The endpoint was the predictors associated with renal insufﬁ-
ciency and subsequent renal function recovery.2.3. Statistical analysis
Categorical variables were evaluated by the Fisher exact test.
Differences in variables with a continuous distribution across
categories were assessed using the Mann–Whitney U test.
Multivariate Cox regression analyses were performed on
predictors of renal insufﬁciency and subsequent renal function
recovery that had a P value <.05 in the univariate analyses. The
signed-rank test for each group was used to compare median
serum creatinine and eGFR at different time points. All reported
P values are two-sided, and statistical signiﬁcance was set at P <
.05. Statistical analyses were performed using the Statistical
Package for Social Sciences, version 23.0, for Windows (IBM
Corp., Armonk, NY, USA).3. Results
The baseline clinical and demographic characteristics of the
patients are shown in Table 1. The median (interquartile range)
age, tumor size, and follow-up period were 53 (45–63) years,
2.6 (1.9–3.8) cm, and 36 (12–48) months, respectively. Tumors
of low complexity were found in 258/393 (65.6%) cases.
Clavien-Dindo complication grade ≥3 occurred in 5.1% (20/
393) of patients. The main reasons for Clavien-Dindo
complication grade ≥3 were hemorrhage (8/20, 40%) followed
by pseudoaneurysm (5/20, 25%). Radical nephrectomy
conversion occurred in 2/20 (0.5%) cases. The median ischemic
time was 25.0 (18.0–31.0) minutes, and there were no
differences according to tumor complexity. The achievement
rates of trifecta and pentafecta were 43.8% and 37.9%,
respectively.
Patients with high complexity had a larger tumor size
(P= .002) and higher Fuhrman grade (≥3) (P= .011) than those
with low complexity. Tumor complexity was signiﬁcantly
associated with complications (P= .005), ischemic time (P
= .005), and PSM (P= .014), but not with postoperative renal
insufﬁciency (P= .943). The achievement rate of trifecta for high
and low complexities was 31.1% and 50.4%, respectively
(P< .001), and the achievement rate of pentafecta was 28.1%,
43.0%, respectively (P= .004). There were no differences in
operative time, type of pedicle clamp, EBL, proportion of renal
insufﬁciency, or follow-up period between the groups according
to renal complexity.
Table 2 shows the change in median eGFR over time according
to clamping type, RENAL nephrometry score, and WIT.
Decreased eGFR at 3 months postoperatively ﬁnally recovered
to near preoperative levels at 2 years (P= .865). Although the
eGFR level at 2 years recovered to the preoperative level
regardless of clamping method, the patterns of the change in
eGFR varied. The patients with WIT ≥25minutes had no
recovery of renal function at 2 years compared to preoperative
levels.
Renal insufﬁciency developed in 54/393 (13.7%) patients, in
which age ≥60 years (hazard ratio [HR], 3.04; conﬁdence
interval [CI], 1.681–5.512; P< .001) and preoperative creatinine
≥1.1mg/ml (HR, 3.57; 95% CI, 2.050–6.202; P< .001) were
independent predictors (Table 3).
Table 1
Baseline clinical and demographic characteristics.
Variables Total RENAL score  7 RENAL score ≥ 8 P value
393 258 (65.6) 135 (34.4)
Age (y) 53.0 (45.0-63.0) 53.5 (45.0–64.0) 53.0 (45.0–61.0) .346
Sex
Male 261 (66.4) 91 (35.3) 41 (30.4) .330
Female 132 (33.6) 167 (64.7) 94 (69.6)
BMI (kg/m2) 24.3 (22.2–26.5) 24.5 (22.1–26.6) 24.0 (22.4–26.1) .865
Comorbidity
ASA ≥ 2 150 (38.2) 99 (38.4) 51 (37.8) .916
Method
Open 118 (30.0) 100 (38.8) 18 (13.3) <.001
Laparoscopy 53 (13.5) 44 (17.1) 9 (6.7)
Robot 222 (56.5) 114 (44.2) 108 (80.0)
Tumor size (cm) 2.6 (1.9–3.8) 2.3 (1.6–3.0) 3.8 (2.7–5.0) .002
Fuhrman grade
≥ 3 95 (24.2) 52 (20.2) 95 (70.4) .011
Preoperative Cr (mg/ml) 0.9 (0.73–1.02) 0.88 (0.70–1.00) 0.91 (0.74–1.04) .239
Preoperative eGFR (ml/minute/1.73 m2) 82.2 (68.0–104.7) 82.8 (67.7–104.1) 81.0 (68.1–105.7) .596
Operative time (minute) 172 (130–219) 176 (135–220) 169 (126–212) .398
Pedicle clamp
Total 294 (74.8) 193 (74.8) 101 (74.8) .373
Selective 63 (16.0) 36 (14.0) 27 (20.0)
No 36 (9.2) 29 (11.2) 7 (5.2)
Estimated blood loss (ml) 400 (200–600) 400 (200–600) 400 (200–625) .226
Complications (Clavien-Dindo classiﬁcation)
G1 25 (6.4) 12 (4.7) 13 (9.6) .005
G2 14 (3.6) 5 (1.9) 9 (6.7)
G3 20 (5.1) 10 (3.9) 10 (7.4)
Ischemic time (minute) 25.0 (18.0–31.0) 23.0 (17.0–30.0) 27.5 (22.8–32.3) .005
Positive surgical margin 27 (6.9) 11 (4.3) 16 (11.9) .014
Renal insufﬁciency 54 (13.7) 35 (13.6) 19 (14.1) .943
Renal function recovery 18 (4.6) 11 (4.3) 7 (5.2) .694
Trifecta achievement 172 (43.8) 130 (50.4) 42 (31.1) <.001
Pentafecta achievement 149 (37.9) 111 (43.0) 38 (28.1) .004
Follow-up period (months) 24.0 (6.0–36.0) 24.0 (6.0–36.0) 24.0 (6.0–48.0) .916
Data are n (%) or median (interquartile range).
ASA=American Society of Anesthesiologists, BMI=body mass index, Cr= creatinine, eGFR= estimated glomerular ﬁltration rate.
Lee et al. Medicine (2019) 98:18 www.md-journal.comAmong these patients, 18/54 (33.3%) patients exhibited renal
function recovery within a median (interquartile range) period of
18 (12–36) months, of which preoperative creatinine<1.1mg/ml
was an independent predictor (HR, 4.38; 95%CI, 1.203–15.911;
P= .025) (Table 4).Table 2
Change in median eGFR over time according to clamping type, REN
Median (IQR) eGFR, ml/minute/1.73 m2
Preoperative 3 months 2 years
Overall 82.2 (68.0–104.7) 75.9 (64.4–91.6) 79.4 (66.3–94
Clamping type
Total 81.6 (67.6–104.5) 75.2 (63.9–89.3) 78.8 (65.8–93
Selective 83.7 (68.0–100.1) 85.4 (70.2–109.4) 77.3 (61.6–85
No 87.5 (74.6–121.4) 77.3 (61.6–85.9) 76.8 (63.3–87
RENAL nephrometry score
<7 82.8 (67.7–104.1) 77.9 (615.2–95.0) 80.8 (66.9–95
≥ 8 81.0 (68.1–105.7) 72.7 (64.1–86.8) 78.2 (64.6–89
WIT
< 25 minutes 83.2 (68.9–105.4) 77.9 (66.2–93.2) 80.9 (70.0–97
≥ 25 minutes 81.6 (67.6–104.5) 74.4 (64.0–89.2) 76.5 (63.8–90
eGFR= estimated glomerular ﬁltration rate, IQR= interquartile range, WIT=warm ischemic time.
34. Discussion
The increasing use of abdominal imaging including ultrasonog-
raphy, CT, andMRI is the main cause for the increasing detection
rate of renal masses.[13] With the dramatically changing
epidemiology of renal masses, PN has been considered theAL nephrometry score, and WIT.
P value for Wilcoxon signed-rank test
2 years vs preop 3 months vs preop 2 years vs 3 months
.4) .865 .005 .026
.8) .652 .003 .026
.9) .394 .480 .754
.4) .695 .073 .110
.7) .606 .046 .104
.0) .390 .046 .122
.1) .050 .324 .020
.6) .043 .005 .366
Table 3
Multivariate analysis for predicting renal insufﬁciency after partial nephrectomy.
Univariate Multivariate
HR 95% CI P value HR 95% CI P value
Age ≥ 60 y 3.90 2.214–6.881 <.001 3.04 1.681–5.512 <.001
Male 1.60 0.859–2.990 .139
BMI 1.02 0.952–1.095 .564
Diabetes mellitus 1.54 0.479–4.934 .470
ASA ≥ 2 1.89 1.093–3.253 .023 1.49 0.851–2.621 .162
Operative methods .189
Open Reference
Laparoscopy 0.56 0.058–5.341 .611
Robot 2.33 0.671–8.119 .183
Tumor size 0.93 0.776–1.111 .417
Pedicle clamp 1.62 0.875–2.995 .125
WIT > 25 minutes 1.25 0.731–2.137 .416
Preoperative creatinine ≥ 1.1 mg/ml 3.88 2.264–6.635 <.001 3.57 2.050–6.202 <.001
RENAL nephrometry score (≥8) 1.08 0.618–1.889 .786
ASA=American Society of Anesthesiologists, BMI=body mass index, CI= conﬁdence interval, HR=hazard ratio, WIT=warm ischemic time.
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A satisfactory oncologic outcome is the cardinal goal of all
surgical methods. Trifecta and pentafecta have been proposed as
measurement tools for the outcomes of PN. Recently published
data reported that trifecta outcomes ranged from 31% to
78%.[8,9,14,15] Because of the lack of a deﬁnition of trifecta for PN
cases and variations in surgical approach and technique, PN
studies using trifecta showed heterogeneous outcomes. We used
complications (Clavien-Dindo complication grade ≥3), PSMs,
and WIT ≥25minsute to evaluate the trifecta achievement rate.
Our achievement rate of trifecta was 43.8%, and this rate is at
least partially similar to the results of previous studies.
Moreover, concerns regarding preservation of renal function
emerged with the increasing demand for PN. Postoperative renal
function after PN is affected by various factors, including
decreasing WIT to reduce the ischemic injury, loss of normal
parenchymal volume to prevent positive surgical margins, and
ischemic damage in preserved tissue during the operation.[16,17]Table 4
Predictors of renal function recovery in patients with renal
insufﬁciency after partial nephrectomy.
Univariate
HR 95% CI Pvalue
Age ≥ 60 y 0.48 0.147–1.567 .224
Male 0.74 0.203–2.717 .653
BMI 0.95 0.792–1.132 .552
Diabetes mellitus 0.94 0.079–11.143 .962
ASA ≥ 2 0.57 0.177–1.809 .337
Operative methods
Open Reference
Laparoscopy 0.50 0.044–5.700 .577
Robot 3.50 0.817–14.986 .091
Tumor size 1.12 0.732–1.726 .593
Pedicle clamp 0.87 0.255–2.994 .830
WIT > 25 minutes 1.41 0.444–4.448 .562
Preoperative creatinine < 1.1 mg/ml 4.375 1.203–15.911 .025
RENAL nephrometry score (≥8) 1.27 0.393–4.117 .687
ASA=American Society of Anesthesiologists, BMI=body mass index, CI= conﬁdence interval, HR=
hazard ratio, WIT=warm ischemic time.
4The optimal threshold of WIT to prevent renal function
deterioration remains controversial. In the trifecta standard,WIT
<25minutes was used, but recent papers proposed the optimal
threshold of WIT to be within 20 minutes.[18,19] Moreover,
Thompson et al found that in patients with a solitary kidney,
every minute of clamping has short- and long-term renal
consequences.[20] In this study, when analyzing WIT at each
minute from 20 to 30 minutes, no signiﬁcant cutoff point was
found. However, WIT ≥25minutes was a factor associated with
prolonged recovery or no recovery of the preoperative eGFR.
Postoperative renal function was related to loss of normal
parenchymal volume and ischemic damage in preserved
tissue.[21,22] Mir MC et al reported that renal function ultimately
was primarily associated with parenchymal volume preservation,
whereas ischemia played a role in the level of renal function
present 4 to 12 months after PN.[22] However, our multicenter
analysis based on long-term follow-up demonstrated that the
type of ischemia was not related to renal function. The results of
this study are expected to be interpreted as a result of
compensatory growth in the contralateral kidney and a more
reﬁned assessment of the effect of ischemia.
The role of various factors inﬂuencing the recovery of renal
function after PN have been investigated, including diabetes,
hypertension, hypercholesterolemia, male sex, old age, smoking,
BMI ≥30kg/m2, vascular disease, use of anti-thrombolytic
medication, remnant renal volume, and surgical methods and
type.[23] However, in our study, only the factor associated with
preoperative renal function, creatinine<1.1mg/ml, was found to
affect renal function recovery.
The RENAL nephrometry score reﬂects the anatomic and
surgical complexity. Several studies investigated the RENAL
nephrometry score as a tool to predict factors associated with
increased operative time, EBL, total renal volume loss, WIT, and
complications.[24,25] In the present study, as expected, WIT,
complication rate, and positive surgical margins statistically
increased with increasing RENAL nephrometry score. However,
no study has predicted long term-renal function using the
RENAL nephrometry score. Recently, Husain et al reported that
healthy renal volume loss or non-neoplastic parenchymal volume
was associated with RENAL nephrometry score.[26] Simmons
Lee et al. Medicine (2019) 98:18 www.md-journal.comMN reported that the RENAL nephrometry score was associated
with changes in the percent of functional volume preservation
and the perioperative functional decrease in an analysis of 237
patients who underwent PN from 2007 to 2010.[24] We found
that the eGFR at 2 years after PN, regardless of complexity, was
not inferior to the preoperative eGFR. To our knowledge, this is
the ﬁrst study to show that the RENAL nephrometry score is not
a prognostic factor predicting renal insufﬁciency and renal
function recovery.
This study has several limitations in addition to its retrospec-
tive design. Heterogeneity of intraoperative management existed.
Patient selection, multiple surgical methods, and techniques
inﬂuenced by the physician’s preference could account for the
heterogeneity in our results. We do not have data on the number
of cases that underwent radical nephrectomy because PNwas not
recommended for small renal mass. In addition, measurement of
the RENAL nephrometry score and pathologic results were not
centrally investigated but were assessed by urologists and
pathologists at each institution. Nevertheless, we believe that
this effect may reﬂect real-world clinical practice and is inherent
in any retrospective study. Finally, we evaluated the parameters
to predict renal function recovery; however, previous studies
have investigated renal functional compensation as a phenome-
non of renal compensatory adaptation.[21,22] In the future, we
plan to evaluate the contribution of ipsilateral atrophy or
contralateral hypertrophy to renal functional recovery after
partial nephrectomy.5. Conclusion
Age ≥60 years and preoperative creatinine ≥1.1mg/ml were risk
factors for renal insufﬁciency following PN. Patients with renal
insufﬁciency whose preoperative creatinine was<1.1mg/ml were
more likely to have renal function recovery.Author contributions
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